Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review

Arthritis Care Res (Hoboken). 2011 Jan;63(1):65-78. doi: 10.1002/acr.20338.
No abstract available

Publication types

  • Comparative Study
  • Review
  • Systematic Review

MeSH terms

  • Animals
  • Antirheumatic Agents / economics*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / economics*
  • Cost-Benefit Analysis / economics
  • Cost-Benefit Analysis / trends
  • Humans
  • Immunologic Factors / economics*
  • Immunologic Factors / therapeutic use*

Substances

  • Antirheumatic Agents
  • Immunologic Factors